Chinese yam polysaccharides (CYPs) have received wide
attention
for their immunomodulatory activity. Our previous studies had discovered
that the Chinese yam polysaccharide PLGA-stabilized Pickering emulsion
(CYP-PPAS) can serve as an efficient adjuvant to trigger powerful
humoral and cellular immunity. Recently, positively charged nano-adjuvants
are easily taken up by antigen-presenting cells, potentially resulting
in lysosomal escape, the promotion of antigen cross-presentation,
and the induction of CD8 T-cell response. However, reports on the
practical application of cationic Pickering emulsions as adjuvants
are very limited. Considering the economic damage and public-health
risks caused by the H9N2 influenza virus, it is urgent to develop
an effective adjuvant for boosting humoral and cellular immunity against
influenza virus infection. Here, we applied polyethyleneimine-modified
Chinese yam polysaccharide PLGA nanoparticles as particle stabilizers
and squalene as the oil core to fabricate a positively charged nanoparticle-stabilized
Pickering emulsion adjuvant system (PEI-CYP-PPAS). The cationic Pickering
emulsion of PEI-CYP-PPAS was utilized as an adjuvant for the H9N2
Avian influenza vaccine, and the adjuvant activity was compared with
the Pickering emulsion of CYP-PPAS and the commercial adjuvant (aluminum
adjuvant). The PEI-CYP-PPAS, with a size of about 1164.66 nm and a
ζ potential of 33.23 mV, could increase the H9N2 antigen loading
efficiency by 83.99%. After vaccination with Pickering emulsions based
on H9N2 vaccines, PEI-CYP-PPAS generated higher HI titers and stronger
IgG antibodies than CYP-PPAS and Alum and increased the immune organ
index of the spleen and bursa of Fabricius without immune organ injury.
Moreover, treatment with PEI-CYP-PPAS/H9N2 induced CD4+ and CD8+ T-cell activation, a high lymphocyte proliferation
index, and increased cytokine expression of IL-4, IL-6, and IFN-γ.
Thus, compared with the CYP-PPAS and aluminum adjuvant, the cationic
nanoparticle-stabilized vaccine delivery system of PEI-CYP-PPAS was
an effective adjuvant for H9N2 vaccination to elicit powerful humoral
and cellular immune responses.